Resverlogix Corp. (TSE:RVX – Get Free Report)’s stock price passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$0.05 and traded as high as C$0.05. Resverlogix shares last traded at C$0.05, with a volume of 3,000 shares changing hands.
Resverlogix Price Performance
The company has a 50-day moving average of C$0.05 and a two-hundred day moving average of C$0.06. The company has a debt-to-equity ratio of -10.95, a current ratio of 0.13 and a quick ratio of 0.04. The stock has a market capitalization of C$8.91 million, a PE ratio of -2.23 and a beta of 0.71.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Articles
- Five stocks we like better than Resverlogix
- Insider Trades May Not Tell You What You Think
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Market Cap Calculator: How to Calculate Market Cap
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
